Biomarkers for cardiovascular-kidney metabolic syndrome: clinical utility in diagnosis, screening, and treatment
Yau K, Cherney DZI, Odutayo A
Diabetes Obes Metab. Pub. online 26 Aug 2025.
Leggi
Cardiovascular and kidney outcomes of GLP-1 receptor agonists in adults with obesity: a target trial emulation study
Tang H, Lu Y, Zhang B, et al.
Diabetes Obes Metab. Pub. online 28 Aug 2025.
Leggi
FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events
27 agosto 2025
Leggi
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee
Bueno H, Deaton C, Farrero M, et al.
Eur Heart J. Pub. online 29 Aug 2025.
Leggi
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
Mach F, Koskinas KC, Roeters van Lennep JE, et al.
Eur Heart J. 2025:ehaf190.
Leggi
Use of risk assessment to guide decision-making for blood pressure management in the primary prevention of cardiovascular disease: a scientific statement from the American Heart Association and American College of Cardiology
Khan SS, Abdalla M, Bello NA, et al.
Circulation. Pub. online 28 Aug 2025.
Leggi
2025 concise clinical guidance: an acc expert consensus statement on adult immunizations as part of cardiovascular care: a report of the American College of Cardiology Solution Set Oversight Committee
A Heidenreich P, Bhatt A, Nazir NT, et al.
J Am Coll Cardiol. Pub. online 21 Aug 2025.
Leggi
Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline
Agarwal A, Mustafa R, Manja V, et al.
BMJ. 2025;390:e082071.
Leggi